Gene · 8434
Papers1,933
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,933
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Profilin and Non-Canonical Wnt Signaling: Coordinating Cytoskeletal Dynamics from Development to Disease. | J Dev Biol | 2025 | 40981267 | PubTator, text mining | PubMed |
| The Association of MicroRNA-21 with Carotid Artery Disease and Ischemic Stroke: From Pathophysiology to Clinical Implications and Potential Therapy. | Med Sci (Basel) | 2025 | 40981170 | PubTator, text mining | PubMed |
| WNT7A/B assemble a GPR124-RECK-LRP5/6 coreceptor complex to activate β-catenin signaling in brain endothelial cells. | J Biol Chem | 2025 | 40914247 | PubTator, text mining | PubMed |
| Role of Ionizing Radiation in Shaping the Complex Multi-Layered Epigenome. | Epigenomes | 2025 | 40843671 | PubTator, text mining | PubMed |
| Apelin as a CNS-specific pathway for fenestrated capillary formation in the choroid plexus. | Nat Commun | 2025 | 40830138 | PubTator, text mining | PubMed |
| Development and validation of nomogram including mutations in angiogenesis-related genes as risk factors for HCC patients treated with TACE. | Transl Oncol | 2025 | 40480146 | PubTator, text mining | PubMed |
| Intercepting Modes of Cellular Communication. | Cell Mol Gastroenterol Hepatol | 2025 | 40348018 | PubTator, text mining | PubMed |
| miR-6516-3p-mediated downregulation of the endogenous MMP-9 inhibitor RECK in mesangial cells might exacerbate lupus nephritis. | Mol Med | 2025 | 40045202 | PubTator, text mining | PubMed |
| RECK as a Potential Crucial Molecule for the Targeted Treatment of Sepsis. | J Inflamm Res | 2025 | 39931174 | PubTator, text mining | PubMed |
| Epidemiological survey on prevalence and subtypes distribution of Blastocystis sp. in Southern Guizhou, China. | Biomol Biomed | 2025 | 39636276 | PubTator, text mining | PubMed |
| Enhancing RECK Expression Through miR-21 Inhibition: A Promising Strategy for Bladder Carcinoma Control. | Biochem Genet | 2025 | 38522065 | PubTator, text mining | PubMed |
| Effect of NQO1 Downregulation on the Migration and Invasion of HPV16-Positive Cervical Cancer Cells. | Asian Pac J Cancer Prev | 2024 | 39733409 | PubTator, text mining | PubMed |
| Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis. | J Vis Exp | 2024 | 39584710 | PubTator, text mining | PubMed |
| Expression of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) Gene and Its Regulation by miR200b in Ovarian Endometriosis. | Int J Mol Sci | 2024 | 39519143 | PubTator, text mining | PubMed |
| EF24, a Curcumin Analog, Reverses Interleukin-18-Induced miR-30a or miR-342-Dependent TRAF3IP2 Expression, RECK Suppression, and the Proinflammatory Phenotype of Human Aortic Smooth Muscle Cells. | Cells | 2024 | 39451191 | PubTator, text mining | PubMed |
| A Role for Impaired RECK Activity in Metabolic Dysfunction-associated Steatotic Liver Disease. | Cell Mol Gastroenterol Hepatol | 2024 | 39186948 | PubTator, text mining | PubMed |
| Analysis of miR-497/195 cluster identifies new therapeutic targets in cervical cancer. | BMC Res Notes | 2024 | 39095857 | PubTator, text mining | PubMed |
| SIAH1 facilitates the migration and invasion of gastric cancer cells through promoting the ubiquitination and degradation of RECK. | Heliyon | 2024 | 38961977 | PubTator, text mining | PubMed |
| RECK/GPR124-driven WNT signaling in pancreatic and gastric cancer cells. | Cancer Sci | 2024 | 38923741 | PubTator, text mining | PubMed |
| Chronic intermittent hypoxia facilitates the development of angiotensin II-induced abdominal aortic aneurysm in male mice. | J Appl Physiol (1985) | 2024 | 38867666 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8434/papers?page=2